tm logo
MEKTOVI & DESIGN
REGISTERED

on 08 Jul 2019

Last Applicant/ Owned by

ARRAY BIOPHARMA INC.

3200 Walnut StreetBoulder, CO 80301

US

Serial Number

1812416 filed on 02th Dec 2016

Registration Number

TMA1037080 registered on 08th Jul 2019

Registration expiry Date

08th Jul 2029

Correspondent Address

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

MEKTOVI & DESIGN

Vienna Information


26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

26 . 2 . 7

Semi-circles, semi-ellipsesDemi-cercles, demi-ellipses

26 . 2 . 24

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée

Trademark usage description

anti-infectives; anti-inflammatories; antibiotics; systemic and topic anti-fungals; antivirals; cardiovascular pharmaceutical preparations; pharmaceut Read More

Classification Information


Class [005]
Anti-infectives; anti-inflammatories; antibiotics; systemic and topic anti-fungals; antivirals; cardiovascular pharmaceutical preparations; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, hyperlipidemia, insulin resistance, metabolic syndrome, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; pharmaceutical preparations for use in hematology and in tissue and organ transplantation, namely, anticoagulants; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating hypertension; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for treating respiratory diseases; pharmaceutical products for treating respiratory diseases and asthma


Classification kind code

10

Mark Details


Serial Number

1812416

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 04th Jan 2019
Allowed
Submitted for opposition 51
on 04th Jan 2019
Allowance Notice Sent
Submitted for opposition 42
on 19th Sep 2018
Advertised
Submitted for opposition 26
on 30th Aug 2018
Approved
Submitted for opposition 27
on 09th Jul 2018
Approval Notice Sent
Submitted for opposition 22
on 01st Dec 2017
Search Recorded
Submitted for opposition 20
on 01st Dec 2017
Examiner's First Report
Submitted for opposition 31
on 06th Dec 2016
Formalized
Submitted for opposition 1
on 05th Dec 2016
Created
Submitted for opposition 30
on 02th Dec 2016
Filed